## BACKGROUND. The recurrence rate of ovarian carcinoma is high even when a second-look laparotomy (SLL) is negative. In the current study, the accuracy of peritoneal cytology as an evaluation method of SLL was examined. ## METHODS. The positive SLL rate and the diagnostic accuracy of peritonea
Prognosticators of second-look laparotomy findings in patients with epithelial ovarian cancer
✍ Scribed by Professor Dr. Ali Ayhan; Hakan Yarali; Osman Develioǧlu; Aykut Üren; Filiz Özyilmaz
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 328 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Prognosticators of outcome at second-look laparotomy (SLL) were evaluated in 49 patients with epithelial ovarian carcinoma undergoing SLL. Residual tumor volume was found to be the most significant prognosticator of outcome, with initial tumor stage being of secondary importance. Grade of tumor played no role in outcome at SLL. The results of the study led us to the conclusion that the second-look procedure may be safely omitted in stage I patients. The importance of optimal cytoreduction during primary surgery was stressed.
📜 SIMILAR VOLUMES
The purpose of the study was to analyze the determinants of long term survival in women with advanced ovarian cancer and negative second-look laparotomy. ## METHODS. A series of 140 advanced (Stage III-rv) ovarian cancer patients (median age, 54 years; range, 22-74 years) with negative second-look
## Abstract ## BACKGROUND. The aim was to determine the long‐term outcome for patients with FIGO stage IV epithelial ovarian carcinoma (EOC) treated with intraperitoneal (IP) chemotherapy after second‐look assessment. ## METHODS. By using data from a retrospective cohort of 433 patients who rece
## Abstract Surgical reexploration was performed in 46 patients with epithelial nonmucinous ovarian adenocarcinoma requiring adjuvant chemotherapy whose initial therapy consisted of optimum debulking and surgical staging. All patients were placed on CAP (cisplatinum, Adriamycin, cyclophosphamide) c